SEC Form 4 · accession 0001465822-16-000001
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeenarine Narine
Other
Period of report
Apr 13, 2016
Accepted (ET)
Apr 15, 2016 · 3:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 13, 2016 | C | 4,000,000 | $0.0625 | A | 16,742,395 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants | $0.0625 | Apr 13, 2016 | C | 333,333 | D | Jun 3, 2009 | Jun 3, 2016 | Common Stock | 333,333 | 0 | D |
| Warrants | $0.0625 | Apr 13, 2016 | C | 2,424,333 | D | Jun 15, 2009 | Jun 15, 2016 | Common Stock | 2,424,333 | 0 | D |
| Warrants | $0.0625 | Apr 13, 2016 | C | 1,242,334 | D | Oct 30, 2009 | Oct 30, 2016 | Common Stock | 1,242,333 | 2,935,986 | D |